The prognosis of metastatic GC patients with high NT5DC2 expression was poor, and NT5DC2 may contribute to the metastases and prognoses of GC by mediating potential pathways, such as the p53 pathway and the cell cycle pathway. This evidence concerns the gene TP53 and gastric cancer.